GRAIL, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
GRAIL, Inc. (GRAL) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $19.56 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06
- GRAIL, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $19.56M, a 36.54% increase year-over-year.
- GRAIL, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $16.79M, a 3.27% increase year-over-year.
- GRAIL, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $14.14M, a 18.70% decline year-over-year.
- GRAIL, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $14.32M, a 1699.37% increase year-over-year.
- GRAIL, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $31.93M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.56M 10-Q · filed 2026-08-06 | $36.35M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $16.79M 10-Q · filed 2026-08-06 | |||
| 2025-09-30 | $14.14M 10-Q · filed 2025-11-13 | $28.47M derived: sum of 2 quarters · filed 2026-08-06 | $44.73M derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-06-30 | $14.32M 10-Q · filed 2026-08-06 | $30.58M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $16.26M 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | $31.93M 10-K · filed 2025-03-05 | |||
| 2024-09-30 | $17.40M 10-Q · filed 2025-11-13 | $18.19M derived: sum of 2 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $796.00K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |